Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Intermittent Catheters Market Size
The global intermittent catheters market was valued at USD 2.6 billion in 2024. The market is expected to grow from USD 2.7 billion in 2025 to USD 3.9 billion in 2034, at a CAGR of 4.1%. An increase in the population suffering from urinary incontinence or neurogenic bladder disorders, coupled with greater awareness of self-catheterization, has positively impacted the growth of the market.
To get key market trends
Moreover, healthcare systems are encouraging self-catheterization as an alternative for bladder control because it presents fewer chances of infection compared to indwelling catheters. The market growth has also been influenced by advancements in catheter technology. The development of new intermittent catheters featuring hydrophilic and antimicrobial coatings, as well as pre-lubricated designs, is intended to encourage patient use while decreasing the risk of urinary tract infections (UTIs). These devices have been made more user-friendly, reducing the stigma associated with self-catheterization.
Intermittent Catheters Market Report Attributes
Report Attribute
Details
Base Year:
2024
Intermittent Catheters Market size in 2024:
USD 2.6 Billion
Forecast Period:
2025 – 2034
Forecast Period 2023 - 2032 CAGR:
4.1
2023 Value Projection:
USD 3.9 Billion
Historical Data for:
2021 – 2024
No of Pages:
160
Tables, Charts & Figures:
228
Segments Covered:
Product Type, Category, Application, Material, End Use, Region
Growth Drivers:
Growing prevalence of urinary diseases
Favorable reimbursement scenario
Growing demand for self-catheterization coupled with expansion of ambulatory surgical centers
Pitfalls Challenges:
Complications associated with catheterization
Availability of alternative treatment options
What are the growth opportunities in this market?
Self-catheterization has led to an increase in the use of sterile, single-use catheters, which has decreased the rate of hospital-acquired infections, pleasing patients and providers alike. Furthermore, the growing need for urinary incontinence treatment devices is expected to further stimulate the market through 2034.
In developing countries, governments and NGOs are striving to make affordable catheters more accessible, particularly for people with disabilities. Besides this, the increase in diabetes and obesity-related urological problems is also benefiting the market since these conditions often cause bladder issues that require catheterization for proper management.
Intermittent catheters are medical devices used by individuals suffering from spinal cord injuries, certain neurological diseases, or urinary incontinence that prevent them from draining urine from the bladder without assistance. These catheters can be used once or multiple times, depending on the design, and are passed through the urethra to drain the bladder. Unlike indwelling catheters, intermittent catheters are removed after each use, which helps reduce the chances of urinary tract infections and promotes better overall urinary tract health.
Intermittent Catheters Market Trends
Self-preference in catheterization, technological advancements, along with heightened awareness of urinary health, are contributing to changes in the market for intermittent catheters. Hydrophilic-coated intermittent catheters, which are comfortable and less abrasive on the urethra, are becoming easier to use.
To help address the problem of catheter-associated urinary tract infections (CAUTI) for long-term users, manufacturers are incorporating antimicrobial properties into some catheter designs. This enhances treatment compliance while also improving catheter options for patients.
There is also a clear trend toward single-use intermittent catheters, as they are sterile with improved infection control. North America and European markets are adopting policies that encourage the use of single-use catheters to reduce the hospital-acquired infections cases.
These trends have resulted in increased demand for disposable catheters, prompting manufacturers to boost their production and expand their range of products in the market. At the same time, sustainability issues are encouraging firms to consider biodegradable catheters, which would mitigate the harmful effects of medical waste. Striking a balance between safety and sustainability necessitates changes in the materials and methods used for production.
The integration of technology is also transforming how the market operates, and catheter management is no exception. Smart catheters that can track urine flow, usage frequency, and other relevant metrics have recently entered the market. This data helps provide effective solutions for patients.
Patients can now learn to self-catheterize through virtual consultations, making it easier to support care at home. E-commerce sites are also facilitating access to catheters, enabling patients to order supplies directly and adhere to treatment regimens more easily.
The improved healthcare infrastructure, combined with increased awareness of self-catheterization in developing countries, is aiding market growth. Both government and non-governmental organizations are striving to make intermittent catheters available and affordable, especially for individuals with disabilities.
Moreover, reimbursement policies in developed countries have made it easier for the elderly to adopt these products. With continuous innovations, regulatory support, and growing supply chains, the market is expected to thrive.
Intermittent Catheters Market Analysis
Learn more about the key segments shaping this market
Based on product type, the market is segmented as coated intermittent catheter and uncoated intermittent catheter. The coated intermittent catheter segment is expected to drive business growth and expand at a CAGR of 4.4%, reaching over USD 2.3 billion by 2034.
The popularity of coated intermittent catheters is increasing as they offer better comfort, reduce friction, and lower the chances of UTIs. The hydrophilic and antimicrobial coatings of modern catheters are beneficial compared to uncoated traditional catheters. For example, hydrophilic-coated catheters are easier and comfortable for people who need long-term catheters as they become slippery when wet. This improvement has made catheterization less painful and more manageable.
Antimicrobial coating is another important feature driving the growth of the coated intermittent catheters segment. These coatings help prevent bacterial growth and reduce the risk of infections, which are common issues with catheter use. Because of this, healthcare providers often recommend coated catheters for patients who are more prone to infections, making them a preferred option in medical settings.
Based on category, the intermittent catheters market is segmented as male length, female length, and pediatric length. The male length segment is expected to drive business growth and expand at a CAGR of 4%, reaching over USD 1.8 billion by 2034.
The design of male-length intermittent catheters is appropriate and suitable for male patients, making them more comfortable and easier to use compared to other catheters. This design allows them to reach the bladder effectively, ensuring it is fully emptied and helping to lower the chances of urinary retention or infections.
Prostate enlargement, spinal cord injuries, and neurological disorders increase the need for intermittent catheterization in men. The increasing occurrence of these conditions drives the growth of this segment.
Based on material, the intermittent catheters market is segmented as PVC, silicone, latex, and other materials. The PVC segment is expected to drive business growth and expand at a CAGR of 4%, reaching over USD 1.7 billion by 2034.
Polyvinyl chloride (PVC) is one of the most commonly used materials for intermittent catheters, holding a large share of the market. PVC catheters are widely preferred because they are durable, affordable, and easy to produce. Their flexibility makes them simple to insert and remove, which improves the overall experience for patients.
The adoption of PVC is increasing due to its ability to be shaped into different sizes and forms. This material is helpful for short-term and long-term use, offering a variety of options to meet the needs of different patients. This material also works well for both male and female patients. Additionally, it can accommodate various catheter lengths, making them a versatile choice for a wide range of users.
Learn more about the key segments shaping this market
Based on end use, the intermittent catheters market is classified into hospitals and specialty clinics, ambulatory surgical centers, and home care settings. The hospitals and specialty clinics segment dominated the market with a revenue share of 44.4% in 2024.
Hospitals and specialty clinics have advanced medical equipment and experienced healthcare professionals who perform catheterization procedures. Hospitals serve a wide variety of patients, including those recovering from surgeries, managing chronic illnesses, or dealing with acute medical issues that require intermittent catheterization. This broad patient base greatly contributes to their market share.
Additionally, the range of diagnostic and therapeutic services available in hospitals and specialty clinics supports the increased use of intermittent catheters. Patients dealing with bladder dysfunction, urinary incontinence, or neurological conditions often need ongoing care and monitoring, making hospitals a preferred choice for their treatment.
Looking for region specific data?
North America: The U.S. intermittent catheters market was valued at USD 927.8 million in 2024 and is projected to grow substantially in the coming years.
The U.S. leads the North American region owing to increasing cases of urinary incontinence, spinal cord injuries and urinary retention. The high adoption of treatment is supported by advanced medical technologies and established reimbursement policies. The elderly population continues to face more urinary disorders, which drives the demand for intermittent catheters. Government healthcare programs like Medicare and Medicaid provide financial assistance for patients to access these products, contributing to market expansion.
Coloplast, Hollister, and B. Braun are some of the key companies that supply these products into the market.
Europe: U.K. intermittent catheters market is projected to grow remarkably in the coming years.
The U.K. is the leading country in Europe for the use of intermittent catheters due to its focus on patient-centric care and advanced medical technologies. The National Health Service (NHS) plays a major role in providing high-quality medical devices such as intermittent catheters to patients suffering from urinary incontinence or bladder issues.
The UK has also witnessed an increase in the use of coated intermittent catheters, which have been shown to decrease UTIs and make the patient more comfortable.
Innovations like hydrophilic-coated catheters are frequently utilized in large hospitals and even at home, catering to individual patient needs.
Asia Pacific: China holds a dominant position in the Asia Pacific intermittent catheters market.
With a large catheter market due to its enormous population and growing healthcare facilities, China is a key player. The increasing urinary problems, particularly in elderly people, create a huge opportunity for market growth.
Domestic players in China are focusing on producing low-cost catheters to meet the growing needs. Additionally, the expansion of private sector healthcare services and awareness about urinary health is boosting the market. Foreign companies are also responding to the high demand for bladder care products by entering the Chinese market through joint ventures and distribution agreements.
Intermittent Catheters Market Share
The leading players including Coloplast, B. Braun, Convatec, and Teleflex contribute more than 50% to the market. These companies invest heavily in research and development to develop new products in the intermittent catheters space. Their strong product portfolio and wide geographic presence help them maintain their market position.
Coloplast is well known for its SpeediCath product line that features hydrophilic and pre-lubricated catheters that are designed to reduce friction and discomfort. Through ongoing innovation, it has become the first choice for healthcare professionals and patients using self-catheterization worldwide.
Convatec, known for its GentleCath line, is making progress by developing intermittent catheters with advanced coatings and better packaging for easy carrying. The company also provides digital educational materials and support tools to help catheter users manage their care better and improve their health outcomes.
Besides these established players, there are also growing companies like Cure Medical, Wellspect (a Dentsply Sirona brand), and CompactCath that are making an impact in the market.
Intermittent Catheters Market Companies
Prominent players operating in the intermittent catheters industry include:
Adapta medical
ASID BONZ
B. Braun
Becton, Dickinson and Company
Coloplast
ConvaTec
Cook
Hollister
Hunter Urology
Pennine Healthcare
Romsons
Teleflex
Wellspect Healthcare
Teleflex is a leading manufacturer of intermittent catheters with its Rüsch catheter portfolio, staying very competitive by meeting the vast amount of patient needs available. They provide different types of intermittent catheters in various lengths, materials, and designs suitable for different medical conditions. The company prioritizes ergonomic and travel-friendly designs, making self-catheterization easier for active users. Teleflex also enhances its products with antimicrobial and hydrophilic coatings, providing extra protection against infections. With a global reach and a focus on home healthcare, Teleflex continues to lead in advancing catheter technology and improving accessibility.
Becton, Dickinson and Company uses its extensive experience in medical devices to deliver dependable and high-quality intermittent catheters. After acquiring C. R. Bard, BD expanded its urology offerings to include the well-known Magic3 Go catheters, which are designed with a three-layer silicone structure for better flexibility and comfort. BD’s commitment to infection control is clear in its closed-system catheter designs, which aim to reduce contamination risks. The company’s strong presence in hospitals and outpatient facilities ensures that its catheter solutions are widely accessible.
B. Braun is another key player, recognized for its Actreen line of intermittent catheters that focus on sterility and ease of use. Being a market leader in the hospital and homecare segments, B Braun is expanding its product portfolio in response to the increasing demand for eco-friendly and single-use catheters. B. Braun also focuses on sustainability by providing PVC- and phthalate-free catheters to reduce environmental harm. Its strong distribution network and commitment to educating patients have built trust among healthcare providers and users worldwide.
Intermittent Catheters Industry News:
In May 2024, Coloplast expanded its Luja portfolio by introducing a next-generation intermittent catheter designed specifically for women. This catheter features over 50 micro-holes, enabling complete bladder emptying in one free flow, thereby reducing the risk of urinary tract infections (UTIs). Clinical studies have demonstrated that 87% of catheterizations with Luja for women experienced zero flow stops, and 83% had less than 10 mL of residual urine at the first flow stop.
In December 2024, Convatec expanded its me+ program, offering more support for intermittent catheter users to help them live with confidence. Originally launched in the U.S. in 2015 and later introduced in other markets, the program provides personalized guidance, product samples, and access to dedicated nurses who offer expert advice over the phone.
In October 2023, HR Pharmaceuticals, Inc. expanded its TruCath portfolio by introducing two new ready-to-use intermittent catheters: the TruCath Hydrophilic Intermittent Catheter and the TruCath Closed System Intermittent Catheter. These products are designed to enhance patient comfort and safety. The hydrophilic catheter features a lubricious coating that activates upon exposure to water, reducing friction during insertion and removal.
In March 2021, Hollister Incorporated announced the U.S. launch of the Infyna Chic intermittent catheter, designed specifically for women seeking a discreet and easy-to-use solution. The catheter features a sleek, pink, pearlescent case that resembles a cosmetic product, allowing for greater discretion. Its unique flip-top cap enables one-handed opening and closing, and the catheter is ready to use without requiring additional lubrication. The design also ensures no leakage when reclosed after use. This product aims to provide women with a convenient and confident catheterization experience.
The intermittent catheters market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
to Buy Section of this Report
Market, By Product Type
Coated intermittent catheter
Hydrophilic
Antimicrobial
Other coated intermittent catheters
Uncoated intermittent catheter
Market, By Category
Male length
Female length
Pediatric length
Market, By Application
Urinary incontinence
General surgery
Spinal injuries
Other applications
Market, By Material
PVC
Silicone
Latex
Other materials
Market, By End Use
Hospitals and specialty clinics
Ambulatory surgical centers
Home care settings
Other end users
The above information is provided for the following regions and countries:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Netherlands
Asia Pacific
China
Japan
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are the key players in the intermittent catheters industry?+
Major players in the industry include Adapta Medical, ASID BONZ, B. Braun, Becton, Dickinson and Company, Coloplast, ConvaTec, Cook, Hollister, and Hunter Urology.
How much is the U.S. intermittent catheters market worth in 2024?+
The U.S. intermittent catheters industry was valued at USD 927.8 million in 2024.
What will be the size of the coated intermittent catheter segment by 2034?+
The coated intermittent catheter segment is expected to exceed USD 2.3 billion by 2034, growing at a CAGR of 4.4%.
How big is the intermittent catheters market?+
The global intermittent catheters industry was valued at USD 2.6 billion in 2024 and is projected to reach USD 3.9 billion by 2034, growing at a CAGR of 4.1% during the forecast period.